Real-world outcomes of axicabtagene ciloleucel in older versus younger adults with diffuse large B-cell lymphoma

Authors

• Adithya Nagendran, Rochester Regional HealthFollow
• Anushree Venkatesh Murthy, Rochester Regional HealthFollow
• Logesh Durairaj, Rochester Regional HealthFollow
• Madho Mal
• Nayanika Chowdary Tummala
• Love Kumar

Department

Internal Medicine

Document Type

Conference Proceeding

Publication Title

Journal of Clinical Oncology

Conference Name

American Society of Clinical Oncology (ASCO) Annual Meeting

Conference Date

2026-05-29 - 2026-06-02

First Page

e19102

DOI

10.1200/JCO.2026.44.16_suppl.e19102

Volume

44

Issue

16_suppl

Publication Date

6-1-2026

Recommended Citation

Nagendran, A., Venkatesh Murthy, A., Durairaj, L., Mal, M., Tummala, N. C., & Kumar, L. (2026). Real-world outcomes of axicabtagene ciloleucel in older versus younger adults with diffuse large B-cell lymphoma. Journal of Clinical Oncology, 44 (16_suppl), e19102. https://doi.org/10.1200/JCO.2026.44.16_suppl.e19102